A series of hybrid molecules between (R)-lipoic acid (ALA) and the acetylated or methylated polyphenol compounds were synthesized and their in vitro cholinesterase [acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE)] inhibition activities were checked. The IC 50 values of all hybrid molecules for a BuChE inhibition were lower than those of the single parent compounds. Specifically, ALA-acetyl protected caffeic acid (11, ALA-AcCA) was shown as an effective inhibitor of BuChE (IC 50 = 0.5 ± 0.2 µM) and also had a great selectivity for BuChE over AChE (more than 800 fold). Inhibition kinetic study indicated that 11 is a mixed inhibition type. Its binding affinity (K i ) value to BuChE is 1.52 ± 0.18 µM.
Introduction
Recently, the single-target-directed drug discovery method has been challenged because 1) many diseases such as diabetes, cancer, cardiovascular disease, neurodegenerative diseases, etc., 1, 2 have been identified as having multiple pathogenic factors and 2) the appearance of drug resistant organisms.
Even though many kinds of efficient drug discovery methods such as the construction of chemical libraries having high molecular diversity, computer-aided drug design (CADD), quantitative structure-activity relationship (QSAR), and High Throughput Screening (HTS) have been developed to solve these problems, it has been still difficult to develop new drugs. Therefore, there are demands to quickly develop the efficient drug development methods. Combinations of different drugs or drug cocktails are candidates, and they have been applied to special diseases. Another good candidate is the hybridization of molecules. Molecular hybridization concept is the combination of appropriate pharmacophores (parents) onto one compound (hybrid molecule). 3 Since parent molecules used in molecular hybridization were already applied to human as a drug or a dietary supplementary, hybrid molecules may show the same or less undesired side effects or toxicity compared to the individual parent molecules. Also they may show better activities compared to the parent and may have new biological activities which parents do not have.
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Scientists have been interested in the natural bioactive compounds and the secondary metabolites as lead compounds for the development of new bioactive compounds. Our group has been carrying out research on the synthesis of novel hybrid molecules between natural bioactive compounds. Previously, we synthesized ALA-nitron hybrid compounds and showed their positive activity for cholinesterase inhibitor. 5 In this work, we selected the ALA and polyphenol (PP) compounds as parents for the synthesis of the hybrid molecules because they showed many interesting biological activities.
ALA and its reduced form, dihydrolipoic acid (DHLA), act as a multifunctional antioxidant against a variety of reactive oxygen species (ROS). 6, 7 ALA is known as the antioxidant of antioxidants because it assists for regeneration and de novo syntheses of endogenous antioxidants such as glutathione, α-tocopherol, and vitamin C. 8 ALA is a cofactor of pyruvate dehydrogenase complex and results in producing an adequate amount of ATP from glucose in aerobic metabolism. 9 The other functions of ALA is a chelator for metal ions such as mercury or iron. 10, 11 ALA is used as a dietary supplement and has been applied to medical treatments such as diabetes, 12-14 ischemia-reperfusion injury, 15 cataract formation, 16 neurodegeneration, [17] [18] [19] and hypertension.
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Many ALA derivatives have been synthesized to improve their biological activities and to give a synergic effect. ALA-L-dopa and ALA-dopamine, 21 ALA-Trolox (a water-soluble analogue of vitamin E), 22 ALA-amphiphilic hybrid of α-phenyl-N-tert-butyl nitrone (PBN) (PBNLP), 23 ALA-nitric oxide synthase inhibitors, 24 and ALA-N-alkyl-substituted morpholine, 25 ALA-chroman analogues, 26 ALA-quinazolinimines, 27 and ALA-quinazolinimines 28 have been synthesized. Polyphenols (PPs) are known as a natural antioxidant due to reduce reactive oxygen species levels in vivo. 29 Therefore, they showed several beneficial results such as reducing the † This paper is dedicated to Professor Eun Lee on the occasion of his honourable retirement. 33, 34 and anti-aging effect by slowing the process of skin wrinkling.
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In this paper, we report the synthesis of the hybrid molecules and their inhibition activity for cholinesterase.
Results and Discussions
Two types of cholinesterases (ChE) exist within the nervous system. One is acetylcholinesterase (AChE, EC 3.1.1.7) that is primarily associated with cholinergic neurons. The other is butyrylcholinesterase (BuChE, EC 3.1.1.8) that is associated with supporting glial cells in the human brain and specific cholinergic nerve tracts. 36 More than 10,000 molecules of acetylcholine (Ach) per second can be hydrolyzed by both cholinesterases at a rate that is limited more by the diffusion of ACh into the enzyme, rather than by catalytic capacity.
37
AChE and BuChE both play important roles in the regulation of ACh level and may also have an important role in the development and progression of Alzheimer's disease (AD).
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Until recently, the relative contribution of BuChE in the regulation of ACh level had been largely ignored. However, there are growing evidences that BuChE may be one of the important enzymes involved for AD. AChE activity is decreased but BuChE activity is increased 40-90% in AD. 39, 40 Also, BuChE activity predominates in cognition and behavior regions of the brain. 41, 42 Selective BuChE inhibition by using cymserine analogs resulted in raising acetylcholine levels in the brains of rodents 43 and BuChE knockout mice and silent mutants in humans show no physiological disadvantage.
44,45
Therefore, development of BuChE-specific inhibitors may be the promising strategy for treating AD without any serious side effects. 46 In this work, we synthesized ALA-polyphenol derivatives and checked their cholinesterase inhibition activity by Ellman's coupled enzyme assay. 47 ALA and polyphenol compounds utilized in this work were listed at Figure 1 .
ALA-acetyl protected-syringic acid (AcSA) was prepared by the activation/coupling reaction (Scheme 1). ALA was initially activated with EDC/NHS in dichloromethane (MC). NHS-activated ALA was reacted with 2-(2-aminoethoxy) ethanol linker to result in compound 3 (73% isolated yield). Acetyl protected syringic acid was converted to acid chloride 4 with SOCl 2 (89% isolated yield). Coupling reaction between 3 and 4 in the presence of DMAP gave rise to compound 5 (ALA-AcSA, 65% isolated yield). Acetyl protection group was removed by treatment of 5 with NH 2 NH 2 in MeOH to form compound 6.
3,4,5-Trimethoxybenzoic acid (TMB), 3,4-dimethoxycinnamic acid (DMC), acetyl protected ferulic acid (AcFA), 4-acetyl protected-3-methoxycinnamic acid (AcMC), and 3,4-diacetyl protected caffeic acid (AcCA) were activated to the corresponding acid chloride and then coupled with 3 to result in the ALA-TMB (7), ALA-DMC (8), ALA-AcFA (9), ALA-AcMC (10), and ALA-AcCA (11), respectively. The synthesized ALA-derivatives were listed in Figure 2 .
The inhibitory results (IC 50 value) for AChE and BuChE with ALA, PPs, acetated-PPs, and ALA-hybridized compounds were shown in Table 1 .
The starting parent compounds didn't show any inhibition activity for cholinesterase. Also, all ALA-derivatives (5-11) showed less than 50% inhibition efficiency at 400 µM for AChE. But all ALA-derivatives improved inhibition activity for BuChE. Specially, the IC 50 values of ALA-AcMC (10) and ALA-AcCA (11) decreased to 1.9 ± 0.7 and 0.5 ± 0.2 µM for BuChE inhibition, respectively. They also showed a great selectivity (more than 800 fold) for BuChE over AChE. Since free phenolic compound 6 obtained from removing acetyl group showed less inhibition effect than acetyl protected compound 5, we didn't carry out deprotection procedure for compounds, 9, 10, & 11.
From the comparison between 8 vs 9, 8 vs 10, 9 vs 11, and 10 vs 11, substitution at meta position with acetyl group would be the most important factor to increase the inhibition efficiency for compounds 8-11. Compound 11, having two acetyl groups at meta and para position, resulted in the best inhibition effect for BuChE. There are several factors for QSAR analysis; hydrophobicity parameter (π), Hammett electronic substituent constant (σ m & σ p ), molar refractivity (MR), etc ( Table 2) . 48 The QSAR parameter values between 3-acetyl and 3-methoxy functional group of aromatic compounds were analyzed. Hydrophilic group substituted at meta position is more important than hydrophobic group (π values : −0.66 for -OAc and −0.02 for -OMe). Since -OAc group is more electron withdrawing group (from Hammett electronic substituent constant value, σ m ) and bigger size (from molar refractivity, MR) than the -OMe group, electron withdrawing effect and bigger size effect might be another important factor to increase inhibition effect at the meta position. Once acetyl group was substituted at the meta position, more hydrophobic, more electron withdrawing, and bigger size functional groups substituted at the para position would increase the BuChE inhibition efficiency.
To explore the inhibition kinetics of 11, inhibition kinetic studies at a different concentration of 11 were carried out. The Lineweaver-Burk plot showed that it was a mixed Lipoic acid >1000 >1000 Caffeic acid >1100 >1100 Acetyl caffeic acid >800 >800 Syringic acid >1000 >1000 Acetyl syringic acid >800 >800 Ferulic acid >1000 >1000 Acetyl ferulic acid >800 >800 3,4,5-Trimethoxy benzoic acid >900 >900 5 (ALA-AcSA) >400 124.0 ± 38.2 6 (ALA-SA) >400 228.7 ± 57.2 7 (ALA-TMB) >400 39.1 ± 0.9 8 (ALA-DMC) >400 26.5 ± 6.4 9 (ALA-AcFA) >400 60.9 ± 17.4 10 (ALA-AcMC) >400 1.9 ± 0.7 11 (ALA-AcCA) >400 0.5 ± 0.2 inhibition type, which varied both V max and K m value (figure 3). The K i value of 11 for BuChE was 1.52 ± 0.18 µM.
Conclusions
Seven hybrid compounds (5-11) were synthesized. Even though the hybrid compounds between ALA and PPs didn't show any big improvement on AChE inhibition efficiency, hybrid ALA-derivatives generally showed high inhibition effect on BuChE inhibition. Specially, the IC 50 value of 10 and 11 was 1.9 ± 0.7 and 0.5 ± 0.2 µM for BuChE inhibition, respectively. The concentration of acetylcholine (ACh) in brain regions of patients suffering Alzheimer's disease (AD) is lower than that of a healthy brain. This cholinergic deficit can be partly corrected by inhibiting ChEs. In healthy brains, AChE predominates (80%) and BuChE is considered to play a minor role in regulating brain ACh levels. But in the AD brain, BuChE activity rises while AChE activity remains unchanged or declines. Recent research indicates that the selective inhibition of BuChE may provide more sustained efficacy over the course of AD and may help to slow disease progression. 49 Indeed, selective BuChE inhibition may provide all the cognitive benefits associated with classical AChE inhibition without the characteristic and dose-limiting adverse effect profile. 50 In general, the majority of potent cholinesterase inhibitors that are the focus of clinical and scientific interest are alkaloids or quaternary ammonium salts.
51 ALA-PP derivatives would become a new type among cholinesterase inhibitors. Since they showed high selective inhibition effect for BuChE rather than AChE, further investigations will be carried out to check the activity against AD. In this study, we reported one example of hybrid molecules that had a positive activity for BuChE inhibition which parents didn't have. Since hybrid molecules synthesized from this work showed new biological activity, molecular hybridization between bioactive natural compounds will be a good candidate to develop biological active compounds. More compounds are now under synthesized to increase inhibition effect and selectivity for BuChE.
Experimental
General Methods. 
H-NMR, and
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C-NMR spectra were recorded on a Varian Mercury 400 (400 MHz) and Bruker ARX-300 (300 MHz). Melting points were determined on SMP3. High-resolution mass spectra (HRMS) were recorded on a JMS-700 Mstation mass spectrometer under fast atom bombardment (FAB) conditions with nitro benzyl alcohol (NBA) as the matrix in the Korea Basic Science Institute (Seoul), Korea. Flash column chromatography was performed using E. Merck silica gel (60, particle size 0.040-0.063 mm). Analytical thin layer chromatography (TLC) was performed using pre-coated TLC plates with silica Gel 60 F254 (E. Merck). All of the synthetic reactions were carried out under argon atmosphere with dry solvent, unless otherwise noted. Tetrahydrofuran (THF) was distilled from sodium/benzophenone immediately prior to use and methylene chloride (CH 2 Cl 2 ) was dried from calcium hydride. All chemicals were reagent grade unless otherwise specified. The (R)-lipoic acid, NHS, and EDC were purchased from Sigma-Aldrich Chemical Co. and used without purification.
Cholinesterase Assay. ChE-catalyzed hydrolysis of the thiocholine esters was monitored by following production of the anion of thiocholine at 412 nm by the Ellman's coupled assay. Assays were conducted on HP8452A or HP8453A diode array UV-visible spectrophotometers and the cell compartments were thermostated by circulating water or Peltier temperature controller, respectively. Acetylthiocholine (ATCh) and butyrylthiocholine (BuTCh) were used as substrates for AChE and BuChE, respectively.
Synthesis. 2-(2-(5-(1,2-Dithiolan-3-yl)pentanamido)ethoxy)ethyl 4-acetoxy-3,5-dimethoxybenzoate (5): (R)-Lipoic acid-linker (30 mg, 0.10 mmol) was dissolved in 3 mL methylene chloride. DMAP (31 mg, 0.15 mmol) were added to the lipoic acid-linker solution. The mixture was stirred for 15 min and then acetyl syringic acid chloride (40 mg, 0.15 mmol) was added to the solution at ice-bath. The mixture was stirred for 3 h at ice-bath and then extracted with 1N NaOH, 1N HCl, and then washed with brine. The combined organic layer was dried over anhydrous MgSO 4 . After the organic solvent was removed under vacuum, the crude product was purified by column chromatography (MC:MeOH = 9:1) to give 5 as an oil (34 mg, 65% yield). 2-(2-(5-(1,2-Dithiolan-3-yl)pentanamido)ethoxy)ethyl 4-hydroxy-3,5-dimethoxybenzoate (6): Compound 5 (100 mg, 0.19 mmol) was dissolved in methanol. Hydrazine monohydrate (0.02 mL, 0.43 mmol) was added to the solution at room temperature. The mixture was stirred at room temperature for 30 min. The reaction mixture was extracted with ethylacetate. The organic layer was washed water and then dried over anhydrous MgSO 4 . After the organic solvent was removed under vacuum, the crude product was purified by column chromatography to give 6 as a white salt (87 mg, 95% yield). 
